Paralytic ileus responding to somatostatin therapy: first manifestation of a VIPoma

Print
Published on Tuesday, 20 January 2015

Letters to the editor

To the Editor:

Referring to the article on the use of somatostatin in patients with pancreatic islet cell tumors in a recent issue of your journal (i.e. "Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors"), we wish to report a case of a malignant VIPoma of the pancreas presenting as a paralytic ileus that responded to somatostatin therapy.

 

 

About this Letter.